Gene · 3399
Papers2,841
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 2,841
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dung biomass smoke exposure impairs resolution of inflammatory responses to influenza infection. | Toxicol Appl Pharmacol | 2022 | 35817128 | PubTator, text mining | PubMed |
| The trichloroethylene metabolite S-(1,2-dichlorovinyl)-l-cysteine inhibits lipopolysaccharide-induced inflammation transcriptomic pathways and cytokine secretion in a macrophage cell model. | Toxicol In Vitro | 2022 | 35811015 | PubTator, text mining | PubMed |
| Biomarker Research Approach to the Pathogenesis of Ossification of the Spinal Ligament: A Review. | Spine Surg Relat Res | 2022 | 35800628 | PubTator, text mining | PubMed |
| A trial design to maximize knowledge of the effects of rodatristat ethyl in the treatment of pulmonary arterial hypertension (ELEVATE 2). | Pulm Circ | 2022 | 35795492 | PubTator, text mining | PubMed |
| Clinical relevance of molecular characteristics in Burkitt lymphoma differs according to age. | Nat Commun | 2022 | 35794096 | PubTator, text mining | PubMed |
| Systematic review of host genomic biomarkers of invasive bacterial disease: Distinguishing bacterial from non-bacterial causes of acute febrile illness. | EBioMedicine | 2022 | 35792524 | PubTator, text mining | PubMed |
| Phenotypic and Immunometabolic Aspects on Stem Cell Memory and Resident Memory CD8+ T Cells. | Front Immunol | 2022 | 35784300 | PubTator, text mining | PubMed |
| Corneal fibrosis abrogation by a localized AAV-mediated inhibitor of differentiation 3 (Id3) gene therapy in rabbit eyes in vivo. | Mol Ther | 2022 | 35780298 | PubTator, text mining | PubMed |
| Emerging Concepts in Innate Lymphoid Cells, Memory, and Reproduction. | Front Immunol | 2022 | 35774779 | PubTator, text mining | PubMed |
| The impact of rare germline variants on human somatic mutation processes. | Nat Commun | 2022 | 35764656 | PubTator, text mining | PubMed |
| Bone morphogenetic protein inhibitors and mitochondria targeting agents synergistically induce apoptosis-inducing factor (AIF) caspase-independent cell death in lung cancer cells. | Cell Commun Signal | 2022 | 35761398 | PubTator, text mining | PubMed |
| Screening Biomarkers for Systemic Lupus Erythematosus Based on Machine Learning and Exploring Their Expression Correlations With the Ratios of Various Immune Cells. | Front Immunol | 2022 | 35757721 | PubTator, text mining | PubMed |
| Recent Advances in Managing Spinal Intervertebral Discs Degeneration. | Int J Mol Sci | 2022 | 35742903 | PubTator, text mining | PubMed |
| Estimating Information Processing of Human Fast Continuous Tapping from Trajectories. | Entropy (Basel) | 2022 | 35741509 | PubTator, text mining | PubMed |
| Harnessing Unconventional T Cells and Innate Lymphoid Cells to Prevent and Treat Hematological Malignancies: Prospects for New Immunotherapy. | Biomolecules | 2022 | 35740879 | PubTator, text mining | PubMed |
| Expression Profiles of ID and E2A in Ovarian Cancer and Suppression of Ovarian Cancer by the E2A Isoform E47. | Cancers (Basel) | 2022 | 35740568 | PubTator, text mining | PubMed |
| The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. | Leukemia | 2022 | 35732829 | PubTator, text mining | PubMed |
| TRAF4 Inhibits Bladder Cancer Progression by Promoting BMP/SMAD Signaling. | Mol Cancer Res | 2022 | 35731212 | PubTator, text mining | PubMed |
| The CDK1/TFCP2L1/ID2 cascade offers a novel combination therapy strategy in a preclinical model of bladder cancer. | Exp Mol Med | 2022 | 35729325 | PubTator, text mining | PubMed |
| The Love-Hate Relationship Between TGF-β Signaling and the Immune System During Development and Tumorigenesis. | Front Immunol | 2022 | 35720407 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3399/papers?page=32